Rheonix

About:

RHEONIX develops automated molecular testing solutions for interchangeable purification, amplification and detection.

Twitter/X: RheonixInc

Top Investors: Advantage Capital, Cayuga Venture Fund, Rand Capital, Onondaga Venture Capital Fund, Gefinor Capital

Description:

Rheonix, Inc. operates as a biomedical device company. Its products include CARD (Chemistry And Reagent Device) system to miniaturize and automate new and existing assays in multiple fields. Its products and technology are used in human/veterinary in vitro diagnostics, food/water testing, SNP analysis for personalized medicine applications, homeland security/defense applications, process control and final product QC, and tissue culture analysis in a research or production setting. Rheonix, Inc. was founded in 2007 and is based in Ithaca, New York.

Total Funding Amount:

$86.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ithaca, New York, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)rheonix.com

Founders:

Gregory J. Galvin

Number of Employees:

51-100

Last Funding Date:

2019-02-13

IPO Status:

Private

Industries: